Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo
- PMID: 16418178
- DOI: 10.1093/brain/awl015
Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo
Abstract
Trauma or disease in the CNS often leads to neuronal death and consequent loss of functional connections. The idea has been put forward that strategies aimed at repairing the injured CNS involve stimulation of both neuronal survival and axon regeneration. We tested this hypothesis in the adult rat retinocollicular system by combining two strategies: (i) exogenous administration of brain-derived neurotrophic factor (BDNF), a potent survival factor for damaged retinal ganglion cells (RGCs) and (ii) lens injury, which promotes robust growth of transected RGC axons. Our results demonstrate that BDNF and lens injury interact synergistically to promote neuronal survival: 71% of RGCs were alive at 2 weeks after optic nerve injury, a time when only approximately 10% of these neurons remain without treatment. Intravitreal injection of BDNF, however, led to regeneration failure following lens injury. The effect of BDNF could not be generalized to other growth factors, as ciliary neurotrophic factor did not cause a significant reduction of lens injury-induced regeneration. Growth arrest in optic nerves treated with BDNF and lens injury correlated with the formation of hypertrophic axonal swellings in the proximal optic nerve. These swellings were filled with numerous vesicular bodies, disorganized neurofilaments and degenerating organelles. Our results demonstrate that: (i) increased neuronal survival does not necessarily lead to enhanced axon regeneration and (ii) activation of survival and growth pathways may produce axonal dystrophy similar to that found in neurodegenerative disorders including glaucoma, Alzheimer's disease and multiple sclerosis. We propose that loss of axonal integrity may limit neuronal recovery in the injured, adult CNS.
Similar articles
-
Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture.Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3943-54. Invest Ophthalmol Vis Sci. 2000. PMID: 11053298
-
Different factors promote axonal regeneration of adult rat retinal ganglion cells after lens injury and intravitreal peripheral nerve grafting.J Neurosci Res. 2008 Mar;86(4):894-903. doi: 10.1002/jnr.21545. J Neurosci Res. 2008. PMID: 18074384
-
Stimulation of axon regeneration in the mature optic nerve by intravitreal application of the toll-like receptor 2 agonist Pam3Cys.Invest Ophthalmol Vis Sci. 2010 Jan;51(1):459-64. doi: 10.1167/iovs.09-4203. Epub 2009 Aug 6. Invest Ophthalmol Vis Sci. 2010. PMID: 19661221
-
Gene therapy and transplantation in the retinofugal pathway.Prog Brain Res. 2009;175:151-61. doi: 10.1016/S0079-6123(09)17510-6. Prog Brain Res. 2009. PMID: 19660654 Review.
-
Traumatology of the optic nerve and contribution of crystallins to axonal regeneration.Cell Tissue Res. 2012 Jul;349(1):49-69. doi: 10.1007/s00441-012-1442-4. Epub 2012 May 26. Cell Tissue Res. 2012. PMID: 22638995 Review.
Cited by
-
Synaptic or Non-synaptic? Different Intercellular Interactions with Retinal Ganglion Cells in Optic Nerve Regeneration.Mol Neurobiol. 2022 May;59(5):3052-3072. doi: 10.1007/s12035-022-02781-y. Epub 2022 Mar 9. Mol Neurobiol. 2022. PMID: 35266115 Free PMC article. Review.
-
Inflammatory Mediators of Axon Regeneration in the Central and Peripheral Nervous Systems.Int J Mol Sci. 2023 Oct 19;24(20):15359. doi: 10.3390/ijms242015359. Int J Mol Sci. 2023. PMID: 37895039 Free PMC article. Review.
-
Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors.Cell Death Dis. 2010;1(2):e27. doi: 10.1038/cddis.2009.23. Cell Death Dis. 2010. PMID: 21364635 Free PMC article.
-
Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.Int J Mol Sci. 2020 Mar 25;21(7):2262. doi: 10.3390/ijms21072262. Int J Mol Sci. 2020. PMID: 32218163 Free PMC article. Review.
-
Glaucoma -state of the art and perspectives on treatment.Restor Neurol Neurosci. 2016;34(1):107-23. doi: 10.3233/RNN-150599. Restor Neurol Neurosci. 2016. PMID: 26684267 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources